Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kalapurakal, J. A.
Right arrow Articles by Marymont, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kalapurakal, J. A.
Right arrow Articles by Marymont, M. H.
(Radiology. 2001;218:157-161.)
© RSNA, 2001


Radiation Oncology

Repositioning Accuracy with the Laitinen Frame for Fractionated Stereotactic Radiation Therapy in Adult and Pediatric Brain Tumors: Preliminary Report1

John A. Kalapurakal, MD, Zainab Ilahi, MD, Alan G. Kepka, PhD, Tomasz Bista, CMD, Stewart Goldman, MD, Tadanori Tomita, MD and Maryanne H. Marymont, MD

1 From the Divisions of Radiation Oncology (J.A.K., Z.I., A.G.K., T.B., M.H.M.), Pediatric Oncology (S.G.), and Pediatric Neurosurgery (T.T.), Northwestern Memorial Hospital, 251 E Huron St, L-178, Chicago, IL 60611. From the 1999 RSNA scientific assembly. Received December 1, 1999; revision requested January 28, 2000; final revision received April 3; accepted May 11. Address correspondence to J.A.K..


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
PURPOSE: To determine the repositioning accuracy, patient tolerance, and clinical efficacy of stereotactic radiation therapy for brain tumors in children and adults performed with the Laitinen stereotactic localizer and head holder.

MATERIALS AND METHODS: In this retrospective analysis, stereotactic frame tolerance was assessed by recording patient discomfort or pain in the ear and nose during each treatment in 34 patients, including 21 children and 13 adults with 37 lesions treated with fractionated stereotactic radiation therapy. Radiation doses ranged from 10–60 Gy at 1.0–4.0 Gy per fraction. Repositioning accuracy was assessed by comparing portal radiographs with setup fields on computed tomographic (CT) scout images. Clinical efficacy was assessed by analyzing posttreatment CT and magnetic resonance images.

RESULTS: The stereotactic localizer was well tolerated. The mean isocenter shifts observed after studying 305 portal radiographs were x-coordinate shift of 1.0 mm ± 0.7 (SD), y-coordinate shift of 0.8 mm ± 0.8, and z-coordinate shift of 1.7 mm ± 1.0. At a median follow-up of 16 months, local control was achieved in 18 of 22 primary and in one of eight of recurrent tumors.

CONCLUSION: The Laitinen stereotactic localizer is well tolerated with accurate reproducibility during stereotactic radiation therapy. Preliminary local control rates are consistent with those in other reports.

Index terms: Brain neoplasms, 10.31, 10.32, 10.33, 10.36 • Brain neoplasms, therapeutic radiology, 10.1267, 10.1269 • Computed tomography (CT), treatment planning, 10.12112, 10.1267 • Magnetic resonance (MR), treatment planning, 10.121412, 10.1267 • Radiations, protective and therapeutic agents and devices • Stereotaxis, 10.1267


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Stereotactic radiosurgery (SRS) and stereotactic radiation therapy (SRT) are increasingly being used in the management of adult and pediatric brain tumors (1). When compared with conventional external-beam irradiation, the use of stereotaxis in target localization and treatment planning allows more precise delivery of radiation dose, thus potentially improving tumor control and decreasing side effects. There are a number of immobilization devices presently in use for SRS and SRT (25). The experience in the United States with the Laitinen stereotactic localizer and head holder (Stereoadapter; Sandstrom Trade & Technology, Welland, Ontario, Canada) is limited (6,7). In this study, we sought to determine the accuracy, patient tolerance, and clinical efficacy of Laitinen stereotactic frame–based SRT in pediatric and adult cases of brain and eye tumors.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
This study was a retrospective analysis of results in adult and pediatric patients with brain and/or eye tumors treated with fractionated SRT by using the Laitinen stereotactic frame. Patient and treatment information was obtained from individual charts, planning computed tomographic (CT) and magnetic resonance (MR) images, and portal radiographs.

Patient and Tumor Characteristics
Between 1995 and 1999, 34 patients with 37 benign or malignant brain and/or eye tumors were treated with SRS or SRT at Northwestern Memorial Hospital in Chicago, Ill (Table). There were 21 children and adolescents with 23 lesions and 13 adults with 14 lesions. The mean and median age of children and adolescents were both 12 years (range, 22 months to 18 years). The mean and median age of adults were both 40 years. (range, 19–77 years). The median follow up was 16 months (range, 0–44 months).


View this table:
[in this window]
[in a new window]

 
Characteristics of Tumors
 
Dose Fractionation
The patients treated with curative intent received 45–60 Gy irradiation at 1.8–2.0 Gy per fraction. The doses used for repeat irradiation ranged from 10–32 Gy at 2–4 Gy per fraction. Three children with choroidal hemangioma received 12 Gy in six fractions. One child with retinoblastoma and another with glioblastoma multiforme received 50 Gy at 1.0 and 1.5 Gy twice a day, respectively, with at least 6 hours between treatments. Prescribed isodose lines encompassing the target volume ranged from 90%–100%.

Immobilization and Target Localization
Since September 1995, we have used the Laitinen stereotactic frame for immobilization and stereotactic localization (Fig 1). This device has been approved by the U.S. Food and Drug Administration for clinical use. It consists of a noninvasive frame made of reinforced plastic and aluminum alloy that is mounted to the patient’s head by means of two earplugs (M, Fig 1) and a nasion support (E, Fig 1). Two cogwheel cases (F, Fig 1) serve to press the nasion support against the bridge of the nose. A threaded screw (D, Fig 1) at the nasion support serves to press the earplugs in both external auditory meatus. The lateral triangular components (G, Fig 1) of reinforced plastic are pressed tightly against the scalp by means of a connector plate over the vertex. A flexible band strapped against the occiput can be used for additional immobilization, if necessary. The lateral triangular component has four transverse bars at a distance of 25 mm from each other. The bars have a dorsoventral thickness of 2 mm. The nasion support arms (F, Fig 1) and the connector plate (I, Fig 1) are supplied with millimeter scales to facilitate exact repositioning of the adapter. A frontal pin joins the two halves of the nasion support assembly. The reference structures of the stereotactic frame are the frontal pin for the lateral x coordinate, a line on the anterior edge of the posterior bars of the lateral triangular components for the anteroposterior y coordinate, and the center of the most inferior transverse bars for the longitudinal z coordinate.



View larger version (120K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1a. Laitinen stereotactic frame mounted on a model of a human skull. A = target plate, B = scale for x coordinate, C = pyramid to confirm isocentricity of table rotation, D = thumbscrew for ear plug, E = nasion support assembly, F = cogwheel with scale for support assembly, G = triangular sidebars, H = adjustable fork, I = connector plate with scale, J = couch adapter fixation screw, K = couch adapter device, L = midline marker, M = ear plugs, N = adapter plate attachment, O = CT adapter plate, P = headrest. (a) Anteroposterior view of the stereotactic frame on the treatment couch of the linear accelerator. (b) Lateral view of the stereotactic frame in the CT adapter apparatus for a Quick CT scanner (GE Medical Systems, Milwaukee, Wis). (c) Superoinferior view of stereotactic frame in the CT adapter apparatus.

 


View larger version (120K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1b. Laitinen stereotactic frame mounted on a model of a human skull. A = target plate, B = scale for x coordinate, C = pyramid to confirm isocentricity of table rotation, D = thumbscrew for ear plug, E = nasion support assembly, F = cogwheel with scale for support assembly, G = triangular sidebars, H = adjustable fork, I = connector plate with scale, J = couch adapter fixation screw, K = couch adapter device, L = midline marker, M = ear plugs, N = adapter plate attachment, O = CT adapter plate, P = headrest. (a) Anteroposterior view of the stereotactic frame on the treatment couch of the linear accelerator. (b) Lateral view of the stereotactic frame in the CT adapter apparatus for a Quick CT scanner (GE Medical Systems, Milwaukee, Wis). (c) Superoinferior view of stereotactic frame in the CT adapter apparatus.

 


View larger version (123K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1c. Laitinen stereotactic frame mounted on a model of a human skull. A = target plate, B = scale for x coordinate, C = pyramid to confirm isocentricity of table rotation, D = thumbscrew for ear plug, E = nasion support assembly, F = cogwheel with scale for support assembly, G = triangular sidebars, H = adjustable fork, I = connector plate with scale, J = couch adapter fixation screw, K = couch adapter device, L = midline marker, M = ear plugs, N = adapter plate attachment, O = CT adapter plate, P = headrest. (a) Anteroposterior view of the stereotactic frame on the treatment couch of the linear accelerator. (b) Lateral view of the stereotactic frame in the CT adapter apparatus for a Quick CT scanner (GE Medical Systems, Milwaukee, Wis). (c) Superoinferior view of stereotactic frame in the CT adapter apparatus.

 
Reproducibility was achieved by (a) noting the lateral separation of the triangular side bars on the metal scale, (b) reading from the nasion support assembly at the cogwheel, and (c) counting the number of turns of the thumbscrew needed to make the plugs fit snugly in the ear canals. Immobilization was achieved by means of the frame’s attachment (N, Fig 1) to the CT adapter plate (O, Fig 1). We used both adult and pediatric versions of the stereotactic frame, which are available for clinical use.

All patients underwent a "fitting session" in the department prior to CT or MR imaging to ascertain the appropriate sizes for the headrest, ear plugs, and settings on the frame. Individual patient data were then recorded on the stereotactic frame data sheet. The Laitinen stereotactic frame is both CT and MR compatible. All patients’ treatments were planned by using CT scans, so that the isocenter could be localized on scout views relative to radiologic landmarks. MR images were obtained when additional diagnostic information was required.

On the day of planning CT, the CT adapter was attached to the scanner couch. The patient was prepared to receive contrast material and was laid on the preselected headrest. The frame was then repositioned on the patient by using the settings from the fitting session. Adjustments were made to head tilt by using polystyrene foam slabs of varying thickness under the headrest to make the posterior ear bars as horizontal as possible to minimize the CT gantry tilt angle. The frame and patient were then squared up with the line lasers of the scanner and were rigidly attached to the couch by means of a multijoint system on the CT adapter insert. A lateral scout view was acquired, from which the gantry tilt angle (<3°) was determined such that the CT sections would be parallel to the transverse bars. This procedure took about 5 minutes.

After administration of contrast material (iopromide, Ultravist; Berlex Laboratories, Wayne, NJ), CT scanning was performed. For CT scans, the patients underwent imaging with a Quick CT scanner (GE Medical Systems) by using the routine head scanning technique (120kVp, 170 mAs, 2 seconds per section, 25-cm field of view). The thinnest section was 3 mm. The data (512 x 512 matrix) were transferred to the treatment-planning computer by means of nine-track magnetic tape. Hard copies ("one on one") of anteroposterior and lateral scout views were obtained to be used for verification of isocenter location.

For MR imaging, the three-dimensional volume was positioned on localizer images to include all aspects of the stereotactic frame. High-spatial-resolution T1-weighted anatomic MR images were acquired (Vision; Siemens Medical Systems, Iselin, NJ) by using a three-dimensional fast low-angle shot sequence with the following imaging parameters: repetition time msec/echo time msec, 15/5.6; flip angle, 20°; field of view, 256 mm; matrix, 256 x 256; section thickness, 1.0 mm. All anatomic sections were obtained in the transverse plane and were transferred to the planning workstation via the hospital network.

Treatment Planning
CT scans and/or MR images obtained with the Laitinen stereotactic frame were utilized for SRT planning by two of the authors (A.G.K., T.B.). Treatment planning was performed with a three-dimensional treatment-planning computer system (Plato; Nucletron, Columbia, Md). Noncoplanar static or rotational beams were used, and the prescribed isodose lines ranged from 90%–100%. All patients were treated with one isocenter for a given lesion. The isocenter was localized on the lateral and anteroposterior scout images, and a localization field was drawn on each. The y and z coordinates were drawn on the target plates, and the x coordinate was referenced to the patient’s midline. The field size varied from 2.5 to 6.0 cm. The number of radiation fields varied from three to eight, with a mean of five. All treatments were delivered by using 6- or 10-MV x rays (model SL 15 linear accelerator; Elekta Instruments, Norcross, Ga).

Treatment Setup and Verification
For each treatment, a couch adapter was attached to the treatment table (Fig 1a). The Laitinen stereotactic frame was mounted on the patient in a fashion similar to the setup in the CT scanner or MR imager. Adjustments were made to level the posterior ear bars relative to the side-localizing lasers before rigidly affixing the frame to the couch adapter by means of a multijoint mechanism. To facilitate target setup, white plastic plates were attached to each of the triangle components of the adapter. The y and z coordinates of the isocenter were marked on the target plates.

The projection of the isocenter on each target plate was then lined up with the side-localization lasers by adjusting the treatment couch. Couch rotation about its midpoint (not about the isocenter) facilitated squaring up of the frame (and patient) relative to the axis of gantry rotation. The mismatch between the target points on the lateral plates and the crosses defined by the side-localization lasers was corrected by using tabletop rotation to correct for half of the error and table in-out motion to correct for the other half of the error. Within two iterations, the patient was on target in the y-z plane. The lateral x coordinate was set relative to the midline of the patient on a linear millimeter scale that was placed perpendicularly on the frontal pin of the adapter. By moving the couch laterally, the frontal laser was brought to coincide with the lateral x coordinate of the target. Thus, the target center was positioned at the isocenter of the linear accelerator.

Orthogonal localization radiographs were obtained before the first treatment and then twice weekly. During each treatment, either the radiation physicist (A.G.K.) or the dosimetrist (T.B.) was present to assist with treatment setup. During treatment, the patient was continuously monitored on a television screen, and no patient required an interruption of treatment because of head motion or discomfort involving the stereotactic frame.

Repositioning Accuracy
The accuracy of the setup was assessed by comparing the portal radiographs obtained during SRT with the setup fields drawn on the CT scout images. The portal radiographs were analyzed in consensus by three of the authors (J.A.K., Z.I., and A.G.K.) to determine the reproducibility of the setup. A transparency was placed over the CT or MR scout image. The central axis and three points of reference at fixed bone landmarks were marked on this image. A line was drawn from the central axis to each point and beyond. Extension of the lines beyond the points allowed coregistration of landmarks independent of magnification. The transparency was superimposed on each portal image. The bone landmarks were then coregistered between the scout and portal images. On the basis of this coregistration, the shift in the central axis was measured directly by using a graduated ruler in the x, y, and z dimensions. This shift measurement had a resolution of 1 mm. Owing to magnification on the portal radiograph (approximately x1.4), this translated to approximately 0.7 mm on the patient.

Tolerance
Patient tolerance to the stereotactic frame was assessed by recording patient discomfort or pain in the ear and nose during each SRT treatment. No specific patient discomfort scales were utilized.

Follow-up
All children were followed up at the multidisciplinary clinic of Northwestern and Children’s Memorial Hospital. Complete neurologic evaluation and MR and/or CT images were obtained at approximately 3-month intervals to assess the response to treatment.

Efficacy
The efficacy of treatment was assessed by comparing manual measurement of tumor dimensions on pre- and posttreatment CT or MR images. Local tumor control was considered to have been achieved if tumor size remained stable or decreased at last follow-up.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Patient Tolerance
The stereotactic frame was well tolerated, and no child required anesthesia or sedation. The ages of the four youngest children in this series were 22 months, 3.0 years, 3.5 years, and 8.0 years. Only one child was not able to tolerate the frame: She experienced marked discomfort from the earplugs in the external auditory canal and was treated by using the Uniframe system (MED-TEC, Orange City, Iowa) for head and neck immobilization. A common complaint was a mild pressure sensation in the ear canals and at the site of the nasal bridge. Even the youngest child, at 22 months of age, did not require sedatives or anxiolytics. The total time required for the first SRT was about 30 minutes; subsequently, it was about 20 minutes for the remaining treatments. There were no frame-setup–related complications, and all children completed therapy without interruption.

Accuracy of Stereotactic Frame Repositioning
A total of 305 portal radiographs, including 160 lateral and 145 anteroposterior portal radiographs, were obtained during the study. The shifts in isocenter in the three coordinates were (a) x-coordinate shift, 0–3.5 mm (mean, 1.0 mm ± 0.7 [SD]); (b) y-coordinate shift, 0–3.0 mm (mean, 0.8 mm ± 0.8); and (c) z-coordinate shift, 0–3.5 mm (mean, 1.7 mm ± 1.0). The SD represents the precision with which patient setup could be performed daily, as measured by the observer (J.A.K., Z.I., A.G.K.).

Local Control and Sequelae
At last follow-up, local control was achieved in five of five patients with craniopharyngioma, in one of four patients with recurrent medulloblastoma, in two of three patients with low-grade glioma, in neither of two patients with high-grade glioma, in both patients with mixed germ cell tumor, in all three patients with choroidal hemangioma, in the patient with choroidal melanoma, in none of four patients with metastases, in both patients with meningioma, in the patient with jugular glomus, in the patient with esthesioneuroblastoma, and in the patient with orbital rhabdomyosarcoma; local control was not achieved in the patient with retinoblastoma. The local control rate was 82% (18 of 22) for primary tumors and 12% (one of eight) for recurrent tumors. These local control rates are preliminary, given the short follow-up. Follow-up in four children was not sufficient to allow comment on local control.

Seventeen patients were followed up for more than 2 years, and at last follow-up there was no evidence of radiation necrosis or radiation-induced damage to cranial nerves in any patient. The incidence of radiation-induced hypopituitarism could not be assessed in the six children with craniopharyngioma because all six had panhypopituitarism after radical surgery. At the time of this writing, none of the children had developed radiation-induced cataract.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
When compared with external-beam irradiation, the use of stereotactic techniques for SRS or SRT provides a superior therapeutic ratio in the management of adult and pediatric brain tumors (Fig 2) (8). In a growing child, improved sparing of a normal developing brain is vital to minimize long-term sequelae, including cataract formation, optic neuropathy, pituitary-hypothalamic dysfunction, neurocognitive deficits, psychologic disturbances, vasculopathy, and induction of second malignant neoplasms (912).



View larger version (73K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2. Transverse CT scan treatment plan for a patient with choroidal hemangioma (T) of the left eye treated with 6-MV x rays and multiple noncoplanar beams, with a field size of 2.5 x 3.5 cm. A 12-Gy dose was prescribed to the 90% isodose line. The 100%, 90%, 50%, 20%, and 10% isodose lines are shown. The posterior border of the lens (L) received 10%-20% of the prescribed dose.

 
An important advantage of SRT over SRS is the superior protection of the brain afforded by the use of fractionated irradiation (13,14). At present, SRS is commonly used in the primary management of benign conditions such as arteriovenous malformation, acoustic neuroma, and meningioma (1517). SRS also is used in conjunction with external-beam irradiation in malignant tumors such as brain metastases and gliomas (18,19). SRT is commonly used in the management of high- and low-grade gliomas, craniopharyngioma, pituitary adenoma, and orbital and ocular tumors (2022).

For SRS, the stereotactic frame is fixed to the skull of the patient to maximize treatment accuracy and minimize errors due to patient motion. The Leksell frame (Elekta Instruments) and the Brown-Roberts-Wells frame (Radionics, Burlington, Mass) are used for SRS with a gamma knife and linear accelerator, respectively (2,3). In a study at the University of Pittsburgh (23), errors in stereotactic coordinate settings occurred in 24 of 200 (12%) isocenters that were studied. This constituted 2.2% (n = 26) of a total of 1,200 individual coordinate settings. Errors in the x-coordinate setting were identified in only one of 400 cases, and this was a 0.25-mm error, resulting in an isocenter displacement of 0.125 mm. A total of eight of 400 y-coordinate and 17 of 400 z-coordinate setting errors greater than 0.25 mm were identified and corrected. There was a significantly higher incidence of y- and z-coordinate errors, as compared with the incidence of x-coordinate errors.

The Joint Center for Radiation Therapy (3) has reported a maximum mechanical error for linear accelerator radiosurgery of 0.90 mm ± 0.30, with a mean of 0.30 mm ± 0.30. Thus, for high-dose single-fraction radiosurgery, invasive stereotactic frames provide accurate patient positioning and precise dose delivery.

For SRT, noninvasive relocatable frames are utilized to provide stereotactic treatment planning capability and accurate daily repositioning during treatment. A number of relocatable frames have been used for SRT, including the Gill-Thomas-Cosman (GTC) frame (Radionics), the Boston Children’s frame (4), and the Laitinen frame (5,6) used in the present study. The GTC frame has an aluminum alloy base ring compatible with the Brown-Roberts-Wells stereotactic system. Mechanical reference for accurate repositioning is provided by an individually constructed oral appliance and an occipital support. The Boston Children’s frame uses ear canal supports because the mouthpiece cannot be reliably used in children. The frame derives its fixation from the glabellar spectacle frame and occipital head supports. Unlike the Laitinen stereotactic frame, the GTC treatment protocol is not reliant on portal radiographs for verification of the accuracy of helmet placement during treatment. Instead, a depth conformation helmet is utilized to measure the depth from 25 fixed positions to the cranial surface in the Brown-Roberts-Wells frame coordinate system. The depth measurements from the depth conformation helmet in 20 patients using the GTC frame indicates a mean measurement error of 0.71 mm ± 0.06 (range, 0.31–1.22 mm), mean lateral movement of 0.35 mm ± 0.06 (range, 0.07–0.79 mm), mean superior movement of 0.52 mm ± 0.09 (range, 0–1.77 mm), and mean occipital movement of 0.34 mm ± 0.09 (range, 0–1.30 mm). The maximum range in individual measurements was 3.4 mm ± 0.6 (4).

As described earlier, the Laitinen stereotactic frame consists of a metal frame that is mounted to the patient’s head by means of two earplugs and a nasion support. This frame has shown a high degree of reproducibility, with an error of no more than 1–2 mm in all coordinates in phantom experiments, volunteers, and patients (5,7,2426). In a series of 10 patients in whom repositioning accuracy was analyzed for 50 setups, the mean distance errors in the three coordinates were 1.82 mm ± 0.7 for x coordinates, 1.5 mm ± 0.5 for y coordinates, and 1.9 mm ± 0.9 for z coordinates (24). An important advantage of the Laitinen stereotactic frame over the GTC frame is its compatibility with MR imagers and lack of need for CT and MR image fusion software. Another advantage is the ability to treat low-lying targets such as tumors below the base of the skull.

One of the advantages of this study was that, to our knowledge, it constituted the largest experience in the United States with the Laitinen stereotactic frame for SRT. The previously reported (24) repositioning accuracy of the stereotactic frame was confirmed by measuring isocenter shifts on over 300 portal radiographs. This frame was well tolerated by the patients, as was demonstrated by the lack of need for anesthesia or sedation in any of the children, including the youngest (22-month-old) child. The local control rates for the different tumors in our series were similar to those in other published reports (13,1618,2022). A limitation of this analysis was the lack of long-term follow-up for assessment of efficacy and complications of stereotactic frame–based SRT. Our results demonstrated that the Laitinen stereotactic frame is well tolerated, with accurate reproducibility of patient fixation during SRT in children and adults with brain and eye tumors.


    FOOTNOTES
 
Abbreviations: GTC = Gill-Thomas-Cosman, SRS = stereotactic radiosurgery, SRT = stereotactic radiation therapy

Author contributions: Guarantors of integrity of entire study, J.A.K., S.G., M.H.M., T.T.; study concepts and design, J.A.K., M.H.M., A.G.K.; definition of intellectual content, J.A.K., M.H.M.; literature research, J.A.K., Z.I., M.H.M.; clinical studies, J.A.K., M.H.M., T.T., S.G., A.G.K., T.B.; data acquisition, J.A.K., Z.I., A.G.K.; data analysis, J.A.K., Z.I., A.G.K., M.H.M., S.G., T.T.; statistical analysis, A.G.K.; manuscript preparation, all authors; manuscript editing, M.H.M., S.G., T.T., A.G.K.; manuscript review, all authors.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Lunsford LD, Kondziolka D, Flickinger JC. Introduction. In: Lunsford LD, Kondziolka D, Flickinger JC, eds. Gamma knife brain surgery. Progress in neurological surgery. New York, NY: Karger, 1998; vol 14:1-4.
  2. Leksell L. Stereotactic radiosurgery. J Neurol Neurosurg Psychiatr 1983; 46:797-803.[Abstract/Free Full Text]
  3. Tsai J, Buck BA, Svensson GK, et al. Quality assurance in stereotactic radiosurgery using a standard linear accelerator. Int J Radiat Oncol Biol Phys 1991; 21:737-748.[Medline]
  4. Kooy HM, Dunbar SF, Tarbell NJ, et al. Adaptation and verification of the relocatable Gill-Thomas-Cosman frame in stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 1994; 3:685-691.
  5. Hariz MI, Henriksson R, Lofroth P, et al. A non-invasive method for fractionated stereotactic irradiation of brain tumors with linear accelerator. Radiother Oncol 1990; 17:57-72.[Medline]
  6. Golden NM, Tomita T, Kepka AG, et al. The use of the Laitinen Stereoadapter for three-dimensional conformal stereotactic radiotherapy. J Radiosurg 1998; 1:191-199.
  7. Weidlich GA, Gebert JA, Fuery JJ. Clinical commissioning of Laitinen Stereoadapter for fractionated stereotactic radiotherapy. Med Dosim 1998; 23:302-306.[Medline]
  8. Flickinger JC, Kondziolka D, Lunsford LD. Principles of dose prescription and risk minimization for radiosurgery. In: Lunsford LD, Kondziolka D, Flickinger JC, eds. Gamma knife brain surgery. Progress in neurological surgery. New York, NY: Karger, 1998; vol 14.:39-50.
  9. Liber KA, Bergloff J, Pendl G. Dose-response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg 1998; 88:43-50.[Medline]
  10. Nedzi L, Kooy HM, Alexander E, et al. Variables associated with the development of complications from radiosurgery of intracranial tumors. Int J Radiat Oncol Biol Phys 1991; 21:591-599.[Medline]
  11. Poussaint TY, Siffert J, Barnes PD, et al. Hemorrhagic vasculopathy after treatment of central nervous system neoplasia in childhood: diagnosis and follow-up. Am J Neuroradiol 1995; 16:693-699.[Abstract]
  12. Waber P, Tarbell NJ, Fairclough D, et al. Cognitive sequelae of treatment in childhood acute lymphoblastic leukemia: cranial radiation requires an accomplice. J Clin Oncol 1995; 13:2490-2496.[Abstract]
  13. Dunbar SF, Tarbell NJ, Kooy HM, et al. Stereotactic radiotherapy for pediatric and adult brain tumors: preliminary report. Int J Radiat Oncol Biol Phys 1994; 30:531-539.[Medline]
  14. Kalapurakal JA, Silverman CL, Akhtar N, et al. Intracranial meningiomas: factors that influence the development of cerebral edema after stereotactic radiosurgery and radiation therapy. Radiology 1997; 204:461-465.[Abstract/Free Full Text]
  15. Flickinger JC, Kondziolka D, Pollock BE, et al. A dose-response analysis of arteriovenous malformation obliteration after radiosurgery. Int J Radiat Oncol Biol Phys 1996; 36:873-879.[Medline]
  16. Kondziolka D, Niranjan A, Lunsford LD, et al. Stereotactic radiosurgery for meningiomas. Neurosurg Clin N Am 1999; 10:317-325.[Medline]
  17. Kondziolka D, Lunsford LD, McLaughlin MR, et al. Long-term outcomes after radiosurgery for acoustic neuromas. N Engl J Med 1998; 339:1426-1433.[Abstract/Free Full Text]
  18. Kondziolka D, Patel A, Lunsford LD, et al. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 1999; 45:427-434.[Medline]
  19. Shrieve DC, Alexander E, Black PM, et al. Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome. J Neurosurg 1999; 90:72-77.[Medline]
  20. Shrieve DC, Kooy HM, Tarbell NJ, Loeffler JS. Fractionated stereotactic radiotherapy. Important Adv Oncol 1996; :205-224.
  21. Tarbell NJ, Loeffler JS. Recent trends in the radiotherapy of pediatric gliomas. J Neurooncol 1996; 28:233-244.[Medline]
  22. Larson DA, Wara WM. Radiotherapy of primary malignant brain tumors. Semin Surg Oncol 1998; 14:34-42.[Medline]
  23. Flickinger JC, Lunsford LD, Kondziolka D, Maitz A. Potential human error in setting stereotactic coordinates for radiosurgery: implications for quality assurance. Int J Radiat Oncol Biol Phys 1993; 27:397-401.[Medline]
  24. Delannes M, Daly NJ, Bonnet J, et al. Fractionated radiotherapy of small inoperable lesions of the brain using a non-invasive stereoadapter. Int J Radiat Oncol Biol Phys 1991; 21:749-755.[Medline]
  25. Hariz M, Eriksson TA. Reproducibility of repeated mountings of a noninvasive CT/MRI stereoadapter. Appl Neurophysiol 1986; 49:336-347.[Medline]
  26. Laitinen LV, Liliequist B, Fagerlund M, et al. An adapter for computed tomography-guided stereotaxis. Surg Neurol 1985; 23:559-566.[Medline]




This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kalapurakal, J. A.
Right arrow Articles by Marymont, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kalapurakal, J. A.
Right arrow Articles by Marymont, M. H.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE